Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 153,324 | 165,455 | 76,332 | 38,872 | N/A |
| Marketable Securities | 27,847 | 14,364 | 46,477 | 1,017 | N/A |
| Receivables | 15,405 | 13,453 | 17,495 | 8,784 | N/A |
| TOTAL | $200,564 | $198,238 | $143,643 | $52,803 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 129,020 | 132,171 | 129,898 | 123,664 | N/A |
| Investments And Advances | 131,720 | 144,269 | 15,356 | 81,613 | 0 |
| Other Non-Current Assets | 9,270 | 8,850 | 8,055 | 7,508 | 0 |
| TOTAL | $270,010 | $285,290 | $153,309 | $212,785 | $N/A |
| Total Assets | $470,574 | $483,528 | $296,952 | $265,588 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,521 | 4,551 | 1,066 | 3,107 | 0 |
| Accrued Expenses | 47,932 | 48,985 | 29,559 | 16,480 | N/A |
| Other current liabilities | N/A | N/A | 710 | 966 | N/A |
| TOTAL | $67,181 | $62,754 | $37,479 | $23,678 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12,728 | 9,218 | 5,741 | 2,393 | N/A |
| Other Non-Current Liabilities | 19,692 | 17,161 | 19,053 | 18,047 | 0 |
| TOTAL | $206,568 | $180,098 | $151,870 | $119,726 | $N/A |
| Total Liabilities | $273,749 | $242,852 | $189,349 | $143,404 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,483 | N/A | N/A | N/A | N/A |
| Common Shares | 620 | 590 | 132 | 132 | N/A |
| Retained earnings | -408,062 | -322,283 | -262,779 | -247,836 | N/A |
| Other shareholders' equity | 17,620 | 16,122 | 329,116 | 332,282 | 0 |
| TOTAL | $196,825 | $240,676 | $107,603 | $122,184 | $N/A |
| Total Liabilities And Equity | $470,574 | $483,528 | $296,952 | $265,588 | $0 |